Medical News

RSS

Current stem cell applications to be discussed at NJIT

Stem cell researcher Treena Livingston Arinzeh will discuss current stem cell applications at NJIT, including the regeneration of bone and cartilage for bone fracture and osteoarthritis treatments, spinal cord repair, and liver regeneration at NJIT's first Research Caf.

25 Sep 2009

Registered Nurses of CNA/NNOC requests meeting with HCA regarding its policy on use of surgical masks

In response to a new policy imposed by the Hospital Corporation of America (HCA) mandating flu shots for all employees and requiring masks, the Registered Nurses of the California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) have requested a meeting with hospital executives on behalf of the chain's 50,000 RNs over this life-and-death issue.

25 Sep 2009

Caliper Life Sciences unveils XenoLight Rediject reagents series at WMIC

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.

25 Sep 2009

Senators fight over Medicare spending cuts, what it would mean for beneficiaries

Senators on the Senate Finance Committee spent much of Wednesday duking it out over proposed Medicare cuts that would fund part of a Democratic push at health care reform. The intensity of the debate highlights the political importance of the senior citizen demographic.

25 Sep 2009

Children exposed to pesticides more susceptible to chilhood leukemia

Northern California Cancer Center (NCCC) research reveals that children exposed to agricultural pesticides applied near their home may experience an increased risk of the most common form of childhood leukemia.

25 Sep 2009

$10 million grant to Weill Cornell Institute from NIMH to study geriatric depression

The Weill Cornell Institute of Geriatric Psychiatry at NewYork-Presbyterian Hospital/Westchester Division announced today it has received the largest grant in its 20-year history. One of a handful awarded nationally, the new $10 million, five-year "Center Grant" from the National Institute of Mental Health (NIMH) will enable NewYork-Presbyterian/Weill Cornell investigators to advance their pioneering work in understanding the biological, medical, cognitive and psychosocial problems of depressed seniors.

25 Sep 2009

Non-accredited education programs for people with chronic disabilities

iMedicor (VMCI.OB) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance agreement to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor/Vemics and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies and has provided a valuable service to the community they serve.

25 Sep 2009

The Adiana permanent contraception system supported by UK's NICE

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the United Kingdom's National Institute for Health and Clinical Excellence (NICE), in its updated guidance for hysteroscopic sterilization, supports the use of Hologic's Adiana((R)) permanent contraception system.

25 Sep 2009

Neogen announces first-quarter results of fiscal 2010

Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.

25 Sep 2009

iCo Therapeutics, CPDD sign collaboration development agreement

iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company has signed a collaboration development agreement with The Consortium for Parasitic Drug Development (CPDD) for the research and development of iCo's oral drug delivery technology for the treatment of neglected diseases such as leishmaniasis and trypanosomiasis. Initial funding of USD $182,930 will be provided for formulation optimization for tropical conditions.

25 Sep 2009

Mayo Clinic's views on how to get high-value health care

Mayo Clinic's perspective about how to get high-value health care is the focus of a Perspectives article in the New England Journal of Medicine, published online on Sept. 23, 2009, and in the print issue on Oct. 1, 2009.

25 Sep 2009

Senate Finance Panel rejects amendment to squeeze drug makers

"Senators rebuffed an attempt to squeeze more money from the drug industry Thursday after two Democrats warned it would undermine the fragile political coalition pushing a sweeping health care overhaul," The Associated Press reports.

25 Sep 2009

Results from COGENT clinical trial presented at TCT symposium

Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested.

25 Sep 2009

Divide deepens between Senate Finance Democrats and Republicans

"Senate Democrats swatted down Republican attempts to make fundamental changes in their health care legislation on Wednesday as the Finance Committee voted on a wide range of amendments that highlighted the deep partisan divide over the bill."

25 Sep 2009

Alcon's patent infringement suit against Synergetics USA stayed

Synergetics USA, Inc., a leading medical device company that designs, manufactures, and markets innovative microsurgical instruments and other devices, today announced that the lawsuit filed by Alcon Research, Ltd. against the Company in the Northern District of Texas, Case No. 4-08CV-609-Y has been stayed in its entirety until both of the patents at issue have completed re-examination in the United States Patent and Trademark Office (“PTO”).

25 Sep 2009

New poll shows only 20 percent say health care is their biggest concern

A new poll shows only one in five respondents say health care is the biggest concern for their family. The Philadelphia Inquirer reports: "Want to know why President Obama continues to have trouble gaining traction in the national debate about health-care reform? A Franklin & Marshall College poll to be released today offers a few key clues."

25 Sep 2009

Versa Card opens the first spine treatment center in Houston

Versa Card, Inc., doing business as "Spine Pain Management, Inc." (the "Company"), is pleased to announce that the first spine treatment center has opened in Houston, Texas.

25 Sep 2009

Prevention and cure of Alzheimer's disease important to Americans

A new voter survey sponsored by the ACT-AD Coalition (Accelerate Cure/Treatments for Alzheimer's Disease) finds that three-quarters of Americans nationwide and across party lines say it is personally important to them to find a cure or to prevent Alzheimer's disease, while a similar proportion of the national electorate say they look to Congress to make it "a national priority" to speed up the Food and Drug Administration's (FDA) review process in specific ways for therapies that slow, halt or reverse the disease.

25 Sep 2009

States worry over Medicaid expansion; Montana expands kids coverage

State officials continue to worry about additional costs that would stem from a Medicaid expansion. Meanwhile, Montana unveils a plan to expand health insurance for children and Iowa Republicans are touting their own alternative to a federal health care overhaul.

25 Sep 2009

FDA provides a conditional approval for Reverse Medical Corporation's ReStore Microcatheter IDE study

Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStore™ Microcatheter at twenty US centers. The study is planned to begin enrollment in US and European hospitals following investigating study center Institutional Review Board (IRB) approvals.

25 Sep 2009